CPS
  • Home

Sign in or register to track your progress, save, and view your completed history.

Gastric Cancer

PD-L1 Interpretation in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

    clockimg 60m
  • Webinar
  • Intermediate
 saveimgSave unsaveimgUnsave

The Precision Pathology Insights webinar series provides expert guidance and essential approaches to help enhance your confidence in Combined Positive Score (CPS) evaluation and strengthen your PD-L1 proficiency. In this webinar, Prof. Manuel Rodriguez-Justo and Dr. Mar Iglesias Coma explore indication-specific nuances of gastric or gastroesophageal junction (GEJ) adenocarcinoma with live case walkthroughs. Recorded 04 December, 2024.

 

Gastrointestinal pathology expert, Prof. Rodriguez-Justo, shares valuable insights on:

  • Indication-specific staining characteristics and morphologies that may impact CPS evaluation
  • Real-world case walkthroughs and scoring demonstrations of gastric and GEJ adenocarcinoma specimens, including a deep-dive into the nuances and challenges of PD-L1 interpretation
  • Tips to ensure accurate and efficient evaluation
  • Interactive Q&A session for discussion and questions 

Manuel Rodríguez-Justo, Prof.​

Gastrointestinal Pathology and Hematopathology Consultant at UCLH, Professor of Onco-pathology at the UCL Cancer Institute

Mar Iglesias Coma, Dr., PhD

Head of Pathology, Hospital del Mar

Related Training

Gastric or GEJ Adenocarcinoma is not yet an approved indication for PD-L1 IHC 22C3 pharmDx (Code SK006) in Europe. Please consult local product Instructions for Use for available diagnostic indications and cutoff values.

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​ D0121904_1.00